GIST, Malignant — POETIG Trial - POnatinib After rEsisTance to Imatinib in GIST
Citation(s)
Phase 2 Trial of Ponatinib in Patients With Metastatic and/or Unresectable Gastrointestinal Stromal Tumor (GIST) Following Failure or Intolerance of Prior Therapy With Imatinib